Bench-to-bedside review: Lactate and the kidney

被引:0
|
作者
Bellomo R. [1 ]
机构
[1] Department of Intensive Care, Austin/Repatriation Medical Centre, Melbourne
来源
Critical Care | / 6卷 / 4期
关键词
Kidney; Lactate;
D O I
10.1186/cc1518
中图分类号
学科分类号
摘要
The native kidney has a major role in lactate metabolism. The renal cortex appears to be the major lactate-consuming organ in the body after the liver. Under conditions of exogenous hyperlactatemia, the kidney is responsible for the removal of 25-30% of all infused lactate. Most of such removal is through lactate metabolism rather than excretion, although under conditions of marked hyperlactatemia such excretion can account for approximately 10-12% of renal lactate disposal. Indeed, nephrectomy results in an approximately 30% decrease in exogenous lactate removal. Importantly and differently from the liver, however, the kidney's ability to remove lactate is increased by acidosis. While acidosis inhibits hepatic lactate metabolism, it increases lactate uptake and utilization via gluconeogenesis by stimulating the activity of phospho-enolpyruvate carboxykinase. The kidney remains an effective lactate-removing organ even during endotoxemic shock. The artificial kidney also has a profound effect on lactate balance. If lactate-buffered fluids are used in patients who require continuous hemofiltration and who have pretreatment hyperlactatemia, the serum lactate levels can significantly increase. In some cases, this increase can result in an exacerbation of metabolic acidosis. If bicarbonate-buffered replacement fluids are used, a significant correction of the acidosis or acidemia can also be achieved. The clinician needs to be aware of these renal effects on lactate levels to understand the pathogenesis of hyperlactatemia in critically ill patients, and to avoid misinterpretations and unnecessary or inappropriate diagnostic or therapeutic activities.
引用
收藏
页码:322 / 326
页数:4
相关论文
共 50 条
  • [1] Bench-to-bedside review: Lactate and the kidney
    Bellomo, R
    [J]. CRITICAL CARE, 2002, 6 (04): : 322 - 326
  • [2] Bench-to-bedside review: Lactate and the lung
    Iscra F.
    Gullo A.
    Biolo G.
    [J]. Critical Care, 6 (4): : 327 - 329
  • [3] Bench-to-bedside review: Lactate and the lung
    Iscra, F
    Gullo, A
    Biolo, G
    [J]. CRITICAL CARE, 2002, 6 (04): : 327 - 329
  • [4] Bench-to-bedside review: Glucose production from the kidney
    Cano, N
    [J]. CRITICAL CARE, 2002, 6 (04): : 317 - 321
  • [5] Bench-to-bedside review: Glucose production from the kidney
    Cano N.
    [J]. Critical Care, 6 (4): : 317 - 321
  • [6] Bench-to-bedside review: Cytopathic hypoxia
    Fink, MP
    [J]. CRITICAL CARE, 2002, 6 (06) : 491 - 499
  • [7] Bench-to-bedside review: Oxygen as a drug
    Haim Bitterman
    [J]. Critical Care, 13
  • [8] Bench-to-bedside review: Carbon dioxide
    Gerard Curley
    John G Laffey
    Brian P Kavanagh
    [J]. Critical Care, 14
  • [9] Bench-to-bedside review: Oxygen as a drug
    Bitterman, Haim
    [J]. CRITICAL CARE, 2009, 13 (01): : 205
  • [10] Bench-to-bedside review: Metabolism and nutrition
    Michaël P Casaer
    Dieter Mesotten
    Miet RC Schetz
    [J]. Critical Care, 12